Delivery Order SPE2DB24D9131-SPE2DB25FXRH2
Award Date
1/10/25
Potential Completion Date
2/3/25
Potential Value
$3.1K
Federal Agency
Defense Logistics Agency
Awardee
DMS Pharmaceutical Group Inc.
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Park Ridge, IL 60068, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of XOLAIR 300 MG/2 ML SYRINGE 2ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $27,907.20, was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business located in Park Ridge, Illinois. The contract is a firm fixed-price delivery order, with a completion date of January 30, 2025. DMS Pharmaceutical Group Inc. has been a key supplier to the DLA, holding a $499,999,999...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business, for the supply of XOLAIR 150 mg/mL syringes. The contract has a ceiling value of $3,094.80 and a period of performance through July 29, 2024. This contract was issued under DMS Pharmaceutical Group's existing indefinite delivery contract (IDC) with the DLA, valued at up to $499,999,999, which supports the recurring pharmaceutical supply...
The U.S. Defense Logistics Agency (DLA) awarded a delivery order contract worth up to $3,094.80 to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract is for the supply of Xolair 150 mg/mL syringes, with a period of performance through April 18, 2024. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, number SPE2DB, valued at up to $4,999,999 through the end of 2025, which allows DLA to issue firm fixed-price...
This federal contract award to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler, is a delivery order valued at $7,737.00 for the supply of XOLAIR 150 MG/ML SYRINGEML to the Defense Logistics Agency (DLA), which is the primary logistics and supply agency for the U.S. Department of Defense. The contract has an ultimate completion date of March 4, 2025 and is a firm fixed-price delivery order, with no set-aside designation. DMS Pharmaceutical Group Inc. holds...
The U.S. Defense Logistics Agency (DLA) awarded a Firm Fixed Price Delivery Order contract to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract, valued at $3,094.80, is for the delivery of Xolair 150 mg/mL syringes to support the recurring medical supply needs of military health facilities. This award is part of a larger Indefinite Delivery Contract (IDC) with DMS Pharmaceutical Group, valued at up to $499,999,999,...
This federal contract award is for the delivery of XOLAIR 150 MG/ML SYRINGEML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency within the Department of Defense. The contract was awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with a ceiling value of $4,642.20 and an ultimate completion date of October 10, 2024. It is part of a larger...
The U.S. government's Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract to DMS Pharmaceutical Group Inc., a woman-owned small business based in Park Ridge, Illinois. The contract, valued at $77,370.00, is for the delivery of XOLAIR 150 MG/ML SYRINGE/ML to the DLA. This delivery order is part of a larger indefinite delivery vehicle (IDV) contract, SPE2DB, that DMS Pharmaceutical Group holds with the DLA, valued at up to $4,999,999 through the end of 2025. The IDV...
This federal contract award is for the delivery of XOLAIR 150 MG/ML syringes to the Defense Logistics Agency (DLA), a defense agency. The contract, valued at $1,547.40, was awarded to DMS Pharmaceutical Group Inc., a for-profit woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract is a firm fixed-price delivery order with an ultimate completion date of April 18, 2024. DMS Pharmaceutical Group holds a larger indefinite delivery contract, contract...
This contract award is for the delivery of XOLAIR 150 MG/ML syringes to the Defense Logistics Agency (DLA), a U.S. Department of Defense agency. The contract, valued at $4,642.20, is a firm fixed-price delivery order awarded to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. The contract has an ultimate completion date of February 20, 2025. DMS Pharmaceutical Group Inc. holds a significant single-award Indefinite Delivery...
The U.S. Defense Logistics Agency (DLA) awarded a firm fixed-price delivery order contract valued at $4,642.20 to DMS Pharmaceutical Group Inc., a woman-owned small business pharmaceutical wholesaler based in Park Ridge, Illinois. This contract is for the supply of XOLAIR 150 MG/ML SYRINGE, a biologic medication, to support the recurring medical needs of military health facilities. The award is part of a larger indefinite delivery contract (IDC) with DMS Pharmaceutical Group valued at up to...